Shuo Ma

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 18

Top Topics

Ejection Fraction

Chronic Lymphocytic Leukemia

Top Venues

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Current hematologic malignancy reports

This page only lists publications with an associated author ORCID identifier.

Publications

Reem Karmali, Rushad Machhi, Narendranath Epperla, Geoffrey Shouse, Jason T Romancik, Tamara K Moyo, Vaishalee P Kenkre, Thomas A Ollila, Lindsey A Fitzgerald, Brian T Hess, Kevin A David, Ishan Roy, Joanna C Zurko, Sayan Mullick Chowdhury, Kaitlin Annunzio, Robert Ferdman, Rahul S Bhansali, Elyse I Harris, Jieqi Liu, Imran A Nizamuddin, Shuo Ma, Jonathan Moreira, Jane N Winter, Barbara Pro, Deborah M Stephens, Alexey V Danilov, Nirav N Shah, Jonathon B Cohen, Stefan K Barta, Pallawi Torka, Leo I Gordon
Impact of Race and Social Determinants of Health on Outcomes in Patients with Aggressive B-cell nHL Treated with CAR-T. Blood advances (2024)
Reem Karmali, Rushad Machhi, Narendranath Epperla, Geoffrey Shouse, Jason T Romancik, Tamara K Moyo, Vaishalee Kenkre, Thomas A Ollila, Lindsey Fitzgerald, Brian Hess, Kevin A David, Ishan Roy, Joanna C Zurko, Sayan Mullick Chowdhury, Kaitlin Annunzio, Robert Ferdman, Rahul S Bhansali, Elyse I Harris, Jieqi Liu, Imran Nizamuddin, Shuo Ma, Jonathan Moreira, Jane Winter, Barbara Pro, Deborah M Stephens, Alexey Danilov, Nirav N Shah, Jonathon B Cohen, Stefan K Barta, Pallawi Torka, Leo I Gordon
Impact of race and social determinants of health on outcomes in patients with aggressive B-cell NHL treated with CAR-T therapy. Blood advances 8 (10) (2024)
Megan Melody, Narendranath Epperla, Geoffrey Shouse, Jason T Romancik, Pamela Blair Allen, Tamara K Moyo, Vaishalee Kenkre, Thomas A Ollila, Lindsey Fitzgerald, Brian Hess, Kevin A David, Megan M Herr, Oluwatobi Odetola, Adam Yuh Lin, Jonathan Moreira, Shuo Ma, Jane N Winter, Ishan Roy, Deborah M Stephens, Alexey Danilov, Nirav N Shah, Stefan K Barta, Matthew Cortese, Jonathon B Cohen, Leo I Gordon, Reem Karmali
Subsequent malignant neoplasms in patients previously treated with anti-CD19 CAR T-cell therapy. Blood advances 8 (10) (2024)
Reem Karmali, Carlos Galvez, Mehdi Hamadani, Leo I Gordon, Jane N Winter, Shuo Ma, Valerie Nelson, Timothy S Fenske, Nirav N Shah, Deepa Jagadeesh, Andreas K Klein, Irene Helenowski, Ruohui Chen, Xinlei Mi, Adam Petrich, Andrew M Evens, Barbara Pro
A Phase I-II Trial of DA-EPOCH-R Plus Ixazomib for MYC-Aberrant Lymphoid Malignancies: The DACIPHOR Regimen. Blood advances (2024)
Reem Karmali, Carlos Galvez, Mehdi Hamadani, Leo I Gordon, Jane Winter, Shuo Ma, Valerie Nelson, Timothy S Fenske, Nirav N Shah, Deepa Jagadeesh, Andreas Klein, Irene Helenowski, Ruohui Chen, Xinlei Mi, Adam Petrich, Andrew M Evens, Barbara Pro
A phase 1-2 trial of DA-EPOCH-R plus ixazomib for MYC-aberrant lymphoid malignancies: the DACIPHOR regimen. Blood advances 8 (7) (2024)
Megan Melody, Narendranath Epperla, Geoffrey Shouse, Jason T Romancik, Pamela Blair Allen, Tamara K Moyo, Vaishalee Kenkre, Thomas A Ollila, Lindsey Fitzgerald, Brian Hess, Kevin A David, Megan M Herr, Oluwatobi Odetola, Adam Yuh Lin, Jonathan Moreira, Shuo Ma, Jane N Winter, Ishan Roy, Deborah M Stephens, Alexey Danilov, Nirav N Shah, Stefan K Barta, Matthew Cortese, Jonathon B Cohen, Leo I Gordon, Reem Karmali
Subsequent malignant neoplasms in patients previously treated with anti-CD19 CAR T-cell therapy. Blood advances 8 (10) (2024)
Reem Karmali, Rushad Machhi, Narendranath Epperla, Geoffrey Shouse, Jason T Romancik, Tamara K Moyo, Vaishalee Kenkre, Thomas A Ollila, Lindsey Fitzgerald, Brian Hess, Kevin A David, Ishan Roy, Joanna C Zurko, Sayan Mullick Chowdhury, Kaitlin Annunzio, Robert Ferdman, Rahul S Bhansali, Elyse I Harris, Jieqi Liu, Imran Nizamuddin, Shuo Ma, Jonathan Moreira, Jane Winter, Barbara Pro, Deborah M Stephens, Alexey Danilov, Nirav N Shah, Jonathon B Cohen, Stefan K Barta, Pallawi Torka, Leo I Gordon
Impact of race and social determinants of health on outcomes in patients with aggressive B-cell NHL treated with CAR-T therapy. Blood advances 8 (10) (2024)
Reem Karmali, Carlos Galvez, Mehdi Hamadani, Leo I Gordon, Jane Winter, Shuo Ma, Valerie Nelson, Timothy S Fenske, Nirav N Shah, Deepa Jagadeesh, Andreas Klein, Irene Helenowski, Ruohui Chen, Xinlei Mi, Adam Petrich, Andrew M Evens, Barbara Pro
A phase 1-2 trial of DA-EPOCH-R plus ixazomib for MYC-aberrant lymphoid malignancies: the DACIPHOR regimen. Blood advances 8 (7) (2024)
Megan Melody, Narendranath Epperla, Geoffrey Shouse, Jason T Romancik, Pamela Blair Allen, Tamara K Moyo, Vaishalee Kenkre, Thomas A Ollila, Lindsey Fitzgerald, Brian Hess, Kevin A David, Megan M Herr, Oluwatobi Odetola, Adam Yuh Lin, Jonathan Moreira, Shuo Ma, Jane N Winter, Ishan Roy, Deborah M Stephens, Alexey Danilov, Nirav N Shah, Stefan K Barta, Matthew Cortese, Jonathon B Cohen, Leo I Gordon, Reem Karmali
Subsequent malignant neoplasms in patients previously treated with anti-CD19 CAR T-cell therapy. Blood advances 8 (10) (2024)
Reem Karmali, Rushad Machhi, Narendranath Epperla, Geoffrey Shouse, Jason T Romancik, Tamara K Moyo, Vaishalee Kenkre, Thomas A Ollila, Lindsey Fitzgerald, Brian Hess, Kevin A David, Ishan Roy, Joanna C Zurko, Sayan Mullick Chowdhury, Kaitlin Annunzio, Robert Ferdman, Rahul S Bhansali, Elyse I Harris, Jieqi Liu, Imran Nizamuddin, Shuo Ma, Jonathan Moreira, Jane Winter, Barbara Pro, Deborah M Stephens, Alexey Danilov, Nirav N Shah, Jonathon B Cohen, Stefan K Barta, Pallawi Torka, Leo I Gordon
Impact of race and social determinants of health on outcomes in patients with aggressive B-cell NHL treated with CAR-T therapy. Blood advances 8 (10) (2024)
Megan Melody, Narendranath Epperla, Geoffrey Shouse, Jason T Romancik, Pamela Blair Allen, Tamara K Moyo, Vaishalee Kenkre, Thomas A Ollila, Lindsey Fitzgerald, Brian Hess, Kevin A David, Megan M Herr, Oluwatobi Odetola, Adam Yuh Lin, Jonathan Moreira, Shuo Ma, Jane N Winter, Ishan Roy, Deborah M Stephens, Alexey Danilov, Nirav N Shah, Stefan K Barta, Matthew Cortese, Jonathon B Cohen, Leo I Gordon, Reem Karmali
Subsequent malignant neoplasms in patients previously treated with anti-CD19 CAR T-cell therapy. Blood advances 8 (10) (2024)
Megan Melody, Narendranath Epperla, Geoffrey Shouse, Jason T Romancik, Pamela Blair Allen, Tamara K Moyo, Vaishalee P Kenkre, Thomas A Ollila, Lindsey A Fitzgerald, Brian T Hess, Kevin A David, Megan M Herr, Oluwatobi Odetola, Adam Yuh Lin, Jonathan Moreira, Shuo Ma, Jane N Winter, Ishan Roy, Deborah M Stephens, Alexey V Danilov, Nirav N Shah, Stefan K Barta, Matthew J Cortese, Jonathon B Cohen, Leo I Gordon, Reem Karmali
Subsequent Malignant Neoplasms in Patients Previously Treated with Anti-CD19 CAR T-Cell Therapy. Blood advances (2024)
Michael L Wang, Wojciech Jurczak, Pier Luigi Luigi Zinzani, Toby Andrew Eyre, Chan Yoon Y Cheah, Chaitra S Ujjani, Youngil Koh, Koji Izutsu, James N Gerson, Ian W Flinn, Benoît Tessoulin, Alvaro J Alencar, Shuo Ma, David John Lewis, Ewa Lech-Maranda, Joanna M Rhodes, Krish Patel, Kami Maddocks, Nicole Lamanna, Yucai Wang, Constantine S Tam, Tahla Munir, Hirokazu Nagai, Francisco Hernandez-Ilizaliturri, Anita Kumar, Timothy S Fenske, John Francis Seymour, Andrew D Zelenetz, Binoj Nair, Donald E Tsai, Minna Balbas, Richard A Walgren, Paolo Abada, Chunxiao Wang, Junjie Zhao, Anthony R Mato, Nirav N Shah
Pirtobrutinib in Covalent BTK-Inhibitor Pre-treated Mantle Cell Lymphoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Peter G Doukas, Frederique St Pierre, Reem Karmali, Xinlei Mi, Jennifer Boyer, Mariana Nieves, Michael G Ison, Jane N Winter, Leo I Gordon, Shuo Ma
Humoral Immunity After COVID-19 Vaccination in Chronic Lymphocytic Leukemia and Other Indolent Lymphomas: A Single-Center Observational Study. The oncologist (2023)
Brian T Hill, Shuo Ma, Clive S Zent, Andrea M Baran, Danielle S Wallace, Anjali S Advani, Allison M Winter, Jane N Winter, Leo I Gordon, Reem Karmali, Jane L Liesveld, Deborah A Mulford, Chris Rowland, Andrew Bui, Peter Sportelli, Hari P Miskin, Michael S Weiss, Jonathan W Friedberg, Paul M Barr
Response-Adapted, Time-Limited Venetoclax, Umbralisib and Ublituximab for Relapsed/Refractory Chronic Lymphocytic Leukemia. Blood advances (2023)
Reem Karmali, Jeremy S Abramson, Deborah M Stephens, Jeffrey A Barnes, Jane N Winter, Shuo Ma, Juehua Gao, Jason Kaplan, Adam M Petrich, Xinlei Mi, Ephraim P Hochberg, Ronald W Takvorian, Valerie Nelson, Leo I Gordon, Barbara Pro
Ibrutinib Maintenance Following Frontline Treatment in Patients with Mantle Cell Lymphoma. Blood advances (2023)
Joanna C Zurko, Imran Nizamuddin, Narendranath Epperla, Kevin A David, Jonathon B Cohen, Tamara Moyo, Thomas A Ollila, Brian T Hess, Ishan Roy, Robert Ferdman, Jieqi Liu, Sayan Mullick Chowdhury, Jason T Romancik, Rahul S Bhansali, Elyse I Harris, Mckenzie Sorrell, Rebecca Masel, Adam S Kittai, Nathan Denlinger, Audrey M Sigmund, Lindsey A Fitzgerald, Carlos Galvez, Shuo Ma, Jane N Winter, Barbara Pro, Leo I Gordon, Alexey V Danilov, Deborah M Stephens, Nirav N Shah, Vaishalee P Kenkre, Stefan K Barta, Pallawi Torka, Geoffrey Shouse, Reem Karmali
Peri-CAR-T practice patterns and survival predictors for all CAR-T patients and post-CAR-T failure in aggressive B-NHL. Blood advances (2022)
Sara Small, Shuo Ma
Frontline Treatment for Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL): Targeted Therapy vs. Chemoimmunotherapy. Current hematologic malignancy reports 16 (4) (2021)